Amgen Inc. (BCBA:AMGN)
Argentina · Delayed Price · Currency is ARS 12,675
+225 (1.81%)
At close: Jul 16, 2025, 5:00 PM BRT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Prolia | 4.37B | Log In | Log In | Log In | Log In | Upgrade |
Prolia Growth | 8.59% | Log In | Log In | Log In | Log In | Upgrade |
ENBREL | 3.32B | Log In | Log In | Log In | Log In | Upgrade |
ENBREL Growth | -11.56% | Log In | Log In | Log In | Log In | Upgrade |
XGEVA | 2.23B | Log In | Log In | Log In | Log In | Upgrade |
XGEVA Growth | 4.35% | Log In | Log In | Log In | Log In | Upgrade |
Nplate | 1.46B | Log In | Log In | Log In | Log In | Upgrade |
Nplate Growth | 1.40% | Log In | Log In | Log In | Log In | Upgrade |
Aranesp | 1.34B | Log In | Log In | Log In | Log In | Upgrade |
Aranesp Growth | -1.70% | Log In | Log In | Log In | Log In | Upgrade |
Other Products | 5.63B | Log In | Log In | Log In | Log In | Upgrade |
Other Products Growth | 20.56% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.40B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -0.37% | Log In | Log In | Log In | Log In | Upgrade |
KYPROLIS | 1.50B | Log In | Log In | Log In | Log In | Upgrade |
KYPROLIS Growth | 2.11% | Log In | Log In | Log In | Log In | Upgrade |
Repatha | 2.22B | Log In | Log In | Log In | Log In | Upgrade |
Repatha Growth | 33.84% | Log In | Log In | Log In | Log In | Upgrade |
Otezla | 2.13B | Log In | Log In | Log In | Log In | Upgrade |
Otezla Growth | -0.96% | Log In | Log In | Log In | Log In | Upgrade |
EVENITY | 1.56B | Log In | Log In | Log In | Log In | Upgrade |
EVENITY Growth | 33.25% | Log In | Log In | Log In | Log In | Upgrade |
BLINCYTO | 1.22B | Log In | Log In | Log In | Log In | Upgrade |
BLINCYTO Growth | 47.31% | Log In | Log In | Log In | Log In | Upgrade |
Vectibix | 1.05B | Log In | Log In | Log In | Log In | Upgrade |
Vectibix Growth | 6.71% | Log In | Log In | Log In | Log In | Upgrade |
TEZSPIRE | 972.00M | Log In | Log In | Log In | Log In | Upgrade |
TEZSPIRE Growth | 68.32% | Log In | Log In | Log In | Log In | Upgrade |
TEPEZZA | 1.85B | Log In | Log In | Log In | Log In | Upgrade |
KRYSTEXXA | 1.19B | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
U.S. | 23.86B | Log In | Log In | Log In | Log In | Upgrade |
U.S. Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of World (ROW) | 9.56B | Log In | Log In | Log In | Log In | Upgrade |
Rest of World (ROW) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
McKesson Corporation Revenue | 22.17B | Log In | Log In | Log In | Log In | Upgrade |
McKesson Corporation Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue | 18.39B | Log In | Log In | Log In | Log In | Upgrade |
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardinal Health, Inc. Revenue | 11.28B | Log In | Log In | Log In | Log In | Upgrade |
Cardinal Health, Inc. Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |